Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.

International journal of oncology

Volumn 23, Issue 1, 2003, Pages 159-163

  De Graff, William G ^a   Myers Jr , L S ^a   Mitchell, James B ^a   Hahn, Stephen M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 IMINODAUNORUBICIN; 5-IMINODAUNORUBICIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DAUNORUBICIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; DRUG DERIVATIVE; FREE RADICAL; HYDROXYBENZOIC ACID DERIVATIVE; PROTOCATECHUIC ACID;

AGAR GEL ELECTROPHORESIS; ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; DNA DAMAGE; DOSE RESPONSE; DRUG ANTAGONISM; HAMSTER; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; CRICETINAE; DAUNORUBICIN; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ELECTROPHORESIS, AGAR GEL; FREE RADICALS; HYDROXYBENZOIC ACIDS; OXIDATION-REDUCTION;

MLCS; MLOWN;

EID: 1542750996     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.23.1.159     Document Type: Article

References (0)